SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

New England Biolabs® announces supply agreement with Lumora

Agreement further strengthens New England Biolabs' position as a key supplier to the molecular diagnostics sector

IPSWICH, Mass., March 6, 2014 /PRNewswire/ -- New England Biolabs, Inc. (NEB®), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing molecular diagnostics market by signing an agreement to manufacture and supply critical reagents to Lumora, a provider of state-of-the-art molecular in vitro diagnostic products.

New England Biolabs logo.

Under the terms of the agreement, NEB will manufacture and supply its proprietary Bst 2.0 DNA Polymerase, a robust enzyme for isothermal amplification and a key component of Lumora's Bioluminescent Assay in Real Time (BART) technology. NEB will also manufacture and supply a range of supporting reagents for use in the development and commercialization of Lumora's molecular diagnostics assay products.

Lumora's Commercial Director Hayden Jeffreys commented, "NEB is one of the leading suppliers of molecular biology enzymes and associated reagents for life science research. This agreement will allow us to access NEB's expertise and reagents, ensuring we are able to provide our customers and partners with the most effective diagnostics."

"We are pleased to formalize our relationship with Lumora by applying our technical and commercial expertise, so that Lumora's technology continues to be a success in the molecular diagnostics market." said Dr. Kiran Gulati, Associate Director, Business Development for Europe at NEB. "NEB has built a strong reputation with a large number of customers across the life sciences sector, and is serving a growing share of molecular diagnostics manufacturers' needs for key reagents. By working with innovative companies with strong technologies, such as Lumora, we can help ensure that these technologies achieve commercial success."

For more information about Bst DNA Polymerase, or NEB's custom capabilities for molecular diagnostics, contact [email protected]

About Lumora

Lumora is a successful provider of state-of-the-art molecular diagnostic products into both the clinical and non clinical or industrial markets. Lumora's easy to deploy and use technology can be employed in fields as diverse as food safety testing, and medical diagnostics. The Company is active in licensing its technology and development partners include international biotechnology, clinical diagnostic and industrial microbiology companies.

Lumora's corporate office is based just outside of Cambridge, England. The Company's investors include; Tate Lyle Ventures LP, Cambridge Enterprise (University of Cambridge), and Catapult Venture Managers Ltd.

www.lumora.co.uk

About New England Biolabs

Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.

NEW ENGLAND BIOLABS® AND NEB® are registered trademarks of New England Biolabs, Inc.

www.neb.com

Logo - http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b

SOURCE New England Biolabs

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.